Get started
Author

Qinghua Lian

Risk factors predicting Candida infective endocarditis in patients with candidemia
2019 · Kap Sum Foong, Abby Sung, et al. · Medical Mycology · 51
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
2025 · Sameem Abedin, Michael J. Martens, et al. · Blood Advances · 17
PDF
Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis
2024 · Ashima Singh, Aniko Szabo, et al. · Blood Cancer Journal · 11
CD19 CAR T‐Cell Therapy for Primary Mediastinal Large B‐Cell Lymphoma: A CIBMTR Analysis
2025 · Jordan Gauthier, Kwang W. Ahn, et al. · American Journal of Hematology · 7
PDF
The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population
2021 · Mythili Srinivasan, Leonard B. Bacharier, et al. · Contemporary Clinical Trials Communications · 7
PDF
Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis
2025 · Kalyan V. Nadiminti, Kwang W. Ahn, et al. · Transplantation and Cellular Therapy · 5
Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation
2024 · Othman S. Akhtar, Shanze Arshad, et al. · Transplantation and Cellular Therapy · 4
An extensive database analysis demonstrates significant increase in platelet quantity in unselected hospitalized patients following treatment with oseltamivir
2024 · Chandrasekar Muthiah, Qinghua Lian, et al. · Haematologica · 4
Random forest analysis identifies change in serum creatinine and listing status as the most predictive variables of an outcome for young children on liver transplant waitlist
2020 · Sakil Kulkarni, Lisa Chi, et al. · Pediatric Transplantation · 4
CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis
2025 · Swetha Kambhampati Thiruvengadam, Kwang Woo Ahn, et al. · American Journal of Hematology · 3
Chimeric antigen receptor T‐cell therapy for high‐grade B‐cell lymphoma NOS
2025 · Nasheed M. Hossain, Kwang Woo Ahn, et al. · British Journal of Haematology · 3
CD19-Directed CAR-T Therapy for Richter Transformation: A CIBMTR Analysis
2025 · Kalyan V Nadiminti, Kwang Woo Ahn, et al. · Transplantation and Cellular Therapy · 3
Sequential monitoring of time-to-event safety endpoints in clinical trials
2024 · Michael J Martens, Qinghua Lian, et al. · Clinical Trials · 2
PDF
Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis
2024 · Sameem Abedin, Qinghua Lian, et al. · Blood · 2
1047. Weight change associated with switching to bictegravir/emtricitabine/tenofovir alafenamide in virally suppressed people with HIV
2020 · Daniel Vo, Charles W Goss, et al. · Open Forum Infectious Diseases · 2
CD19-Directed CAR-T Therapy for Transformed Follicular Lymphoma: A CIBMTR Analysis
2025 · Swetha Thiruvengadam, Kwang Woo Ahn, et al. · Transplantation and Cellular Therapy · 1
Real-World Outcomes of CD19 CAR T-Cell Therapy in Patients with Primary Mediastinal B-Cell Lymphoma and Impact of Prior ICI Treatment: A CIBMTR Analysis
2025 · Jordan Gauthier, Kwang W. Ahn, et al. · Transplantation and Cellular Therapy · 1
CAR T Outcomes in Patients with High-Grade B-Cell Lymphoma Not Otherwise Specified (HGBL-NOS): A CIBMTR Analysis
2025 · Nasheed M. Hossain, Kwang W. Ahn, et al. · Transplantation and Cellular Therapy · 1
Group sequential clinical trial designs for composite endpoints incorporating recurrent and terminal events
2026 · Qinghua Lian, Kwang Woo Ahn, et al. · Biometrics
TITE-safety: a robust time-to-event safety monitoring approach for clinical trials
2026 · Michael J Martens, Qinghua Lian, et al. · Biometrics
gsMeanFreq: Group Sequential Clinical Trial Designs for Composite Endpoints
2026 · Qinghua Lian, Michael J Martens
PDF
TITE-Safety: Time-to-event Safety Monitoring for Clinical Trials
2025 · Martens, Michael J., Lian, Qinghua, et al. · arXiv (Cornell University)
PDF
SurvImpute: Multiple Imputation for Missing Covariates in Time-to-Event Data
2025 · Qinghua Lian, Soyoung Kim, et al.
PDF
Timing and co-occurrence of red-flag diagnoses prior to a diagnosis of systemic light chain (AL) amyloidosis PA5 (#147)
2024 · Anita D'Souza, Ashima Singh, et al.
Differences in Light Chain (AL) Amyloidosis Epidemiology By Race and Ethnicity
2022 · Ashima Singh, Aniko Szabo, et al. · Blood
Works count: 25
Citation count: 128
H-index: 5
I10-index: 3
Year
Topic
Type